NL-OMON20831
Not Yet Recruiting
N/A
Immunity induced by yellow fever vaccination in the elderly (60yrs or older)traveller
A.H.E. Roukens en L.G. Visser0 sites60 target enrollmentTBD
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- gele koorts, oudere, reizen, neutraliserende antistoffen, bijwerkingenyellow fever, elderly, travel, neutralizing antibodies, adverse events
- Sponsor
- A.H.E. Roukens en L.G. Visser
- Enrollment
- 60
- Status
- Not Yet Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Elderly group:
- •1\. Age of 60yrs or older;
- •2\. Indication for yellow fever vaccination according to Dutch travel guidelines
- •Control group: age under 60yrs
Exclusion Criteria
- •1\. Immune suppression due to disease or medication;
- •2\. Pregnancy
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
N/A
Immunity after yellow fever vaccination in travelers using immunosuppressive medication-YETI studyYellow Fever infection10047438NL-OMON37037Academisch Medisch Centrum75
Completed
N/A
ong-term immunity after Yellow fever vaccinatioYellow feverJPRN-UMIN000040526Tokyo Medical University Hospital Travellers' Medical Center50
Active, Not Recruiting
N/A
Immunity of the Vaccine against Yellow Fever in patients taking medications that affect the immune systemnspecified rheumatoid arthritisM06.9RBR-946bv5Centro de Pesquisas René Rachou- FIOCRUZ
Active, Not Recruiting
N/A
Study of Yellow Fever Vaccine Administered With Sanofi Pasteur's Dengue Vaccine in Healthy Toddlers at 12-13 Months of Age in Colombia and PeruPrevention of symptomatic dengue diseaseTherapeutic area: Diseases [C] - Virus Diseases [C02]EUCTR2014-001714-26-Outside-EU/EEASanofi Pasteur SA792
Completed
N/A
Immunity after yellow fever vaccination in HIV positive travelers - YELLAR studyYellow Fever Infection10047438NL-OMON39974Academisch Medisch Centrum60